🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A fantastic line up has been confirmed for the EHTGtweets virtual meeting in 2024. Great value for money. Great science. Great opportunity to present and discuss collaboration. See ehtg.org for more. Gabriela Moeslein BGCS fellows Lynch Syndrome Intl

We're thrilled to share a campaign dedicated to Lynch syndrome, a condition close to many hearts. 💙 Get ready to embark on an incredible personal journey of living with Lynch. #LynchSyndromeAwareness #StrengthInStories

Chapter I of #livingwithlynch In this chapter, Heinke is sharing how the topic of Lynch syndrome entered her life. More on Heinke's story on Instagram (semicolon_de, atbheidelberg, ehtg_official) #strengthinstories #lynchsyndromeawareness

Next chapter of #livingwithlynch We continue to share Heinke's Lynch syndrome journey now highlighting her considerations before taking the genetic test. More on Heinke's story on Instagram (ehtg_official, semicolon_de, atbheidelberg). #strengthinstories #lynchsyndromeawareness

The next chapter of Heinke's #livingwithlynch is out, this time touching upon prevention and early detection. More on Instagram (ehtg_official, semicolon_de, atbheidelberg). #strengthinstories #lynchsyndromeawareness

Heinke's story of #livingwithlynch continues with a next chapter. Learn more about her #lynchsyndrome journey on Instagram (ehtg_official, semicolon_de, atbheidelberg). #strengthinstories #lynchsyndromeawareness

Abstract submission for EHTG 2024 is now open! Be sure to submit your research before June 5th and get a chance to present your data at the EHTG Virtual meeting this year. Follow the link below for more information. linktr.ee/ehtg.org #callforabstracts #ehtg2024 #conference

We invite you to join us for in the 8th EHTG online meeting, with great speakers and topics

Let's meet next month at the EHTG online meeting.

EHTG 2024 features a dedicated session on desmoid disease. Join us on September 27th to learn from Prof. Yann Parc on the surgical treatment options for patients with desmoid disease. #ehtg2024

We are lucky to have Prof. Silvia Stacchiotti join the EHTG 2024 faculty with her expertise in desmoid disease. Don't miss her talk about medical treatment options for desmoid disease on September 27th. #ehtg2024

Join us for a cutting-edge session on cancer prevention at the European Hereditary Tumor Group Meeting 2024, where top experts will share the latest updates in hereditary cancer prevention. Don‘t miss Ann-Sofie Backman presenting findings from the MESACapp study

The cancer prevention session at the European Hereditary Tumor Group Meeting 2024 will feature in-depth presentations from leading researchers: Join us, Andrew Chan discuss the role of aspirin in hereditary cancer prevention, offering new insights into its clinical applications.

Join us at the EHTG Meeting 2024 for a pivotal session on cancer prevention. Don’t miss the opportunity to hear Matthias Kloor as he delves into pioneering immune prevention strategies for Lynch syndrome, revealing how we can utilize the immune system to prevent hereditary cancer

Thrilled to introduce Prof. Phil Quirke, our Keynote Speaker on September 27, and his talk on the role of microbiome in cancer prevention! #ehtg2024

Join our Keynote Speaker, Sir Harpal Kumar, on September 28th and find out more about the potential of liquid biopsy in hereditary cancer research! #ehtg2024

Immunotherapy has revolutionized the treatment options and management of patients with MSI-H colorectal cancer.  Therapy selection in specific clinical cases, patients with genetic predisposition, residual disease, synchronous tumors, long-term success and adverse events.

One of the EHTG's main goals is to support early career scientists and to raise the next generation of experts in hereditary cancer syndromes. This is why this year's meeting again has a dedicated Young-EHTG session highlighting the projects of young scientists.